- Home
- STAA vs HUMAW Comparison
STAA vs HUMAW Comparison
Compare STAA & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STAA
- HUMAW
- Stock Information
- Founded
- STAA 1982
- HUMAW 2004
- Country
- STAA United States
- HUMAW United States
- Employees
- STAA N/A
- HUMAW 185
- Industry
- STAA Ophthalmic Goods
- HUMAW Biotechnology: Pharmaceutical Preparations
- Sector
- STAA Health Care
- HUMAW Health Care
- Exchange
- STAA Nasdaq
- HUMAW Nasdaq
- Market Cap
- STAA N/A
- HUMAW N/A
- IPO Year
- STAA N/A
- HUMAW N/A
- Fundamental
- Price
- STAA $16.89
- HUMAW $0.40
- Analyst Decision
- STAA Buy
- HUMAW
- Analyst Count
- STAA 9
- HUMAW 0
- Target Price
- STAA $30.71
- HUMAW N/A
- AVG Volume (30 Days)
- STAA 1.1M
- HUMAW 14.2K
- Earning Date
- STAA 05-06-2025
- HUMAW 03-21-2025
- Dividend Yield
- STAA N/A
- HUMAW N/A
- EPS Growth
- STAA N/A
- HUMAW N/A
- EPS
- STAA N/A
- HUMAW N/A
- Revenue
- STAA $313,901,000.00
- HUMAW N/A
- Revenue This Year
- STAA N/A
- HUMAW N/A
- Revenue Next Year
- STAA $25.89
- HUMAW N/A
- P/E Ratio
- STAA N/A
- HUMAW N/A
- Revenue Growth
- STAA N/A
- HUMAW N/A
- 52 Week Low
- STAA $13.50
- HUMAW $1.18
- 52 Week High
- STAA $49.86
- HUMAW $1.34
- Technical
- Relative Strength Index (RSI)
- STAA 48.31
- HUMAW N/A
- Support Level
- STAA $14.69
- HUMAW N/A
- Resistance Level
- STAA $17.50
- HUMAW N/A
- Average True Range (ATR)
- STAA 1.10
- HUMAW 0.00
- MACD
- STAA 0.08
- HUMAW 0.00
- Stochastic Oscillator
- STAA 61.97
- HUMAW 0.00
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.